Jon R Resar
Overview
Explore the profile of Jon R Resar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
1049
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zinoviev R, Hasan R, Gammie J, Resar J, Czarny M
J Am Heart Assoc
. 2024 Jan;
13(2):e029875.
PMID: 38214264
Background: Mitral regurgitation (MR) is the most common valvular disease in the United States and increases the risk of death and hospitalization. The economic burden of MR in the United...
2.
Denis R, Hasan R, Post W, Resar J, Zimmerman S, Czarny M
Am J Cardiol
. 2023 Oct;
208:116-117.
PMID: 37832207
No abstract available.
3.
Rahman F, Mehta H, Resar J, Hasan R, Marconi W, Aziz H, et al.
Front Cardiovasc Med
. 2023 Aug;
10:1194360.
PMID: 37600049
Background: While there is evidence that patients with low-flow, low-gradient aortic stenosis (AS) benefit from transcatheter aortic valve replacement (TAVR), data are lacking regarding outcomes of patients with a very...
4.
Damluji A, Ijaz N, Chung S, Xue Q, Hasan R, Batchelor W, et al.
JACC Adv
. 2023 Aug;
2(3).
PMID: 37538136
Background: Frailty and cognitive impairment (CI) are geriatric conditions that lead to poor health outcomes among older adults with cardiovascular disease. The association between their temporal patterns of development and...
5.
Yesantharao P, Etchill E, Zhou A, Ong C, Metkus T, Canner J, et al.
Catheter Cardiovasc Interv
. 2023 Apr;
101(7):1193-1202.
PMID: 37102376
Background: Transcatheter aortic valve replacement (TAVR) is an increasingly used but relatively expensive procedure with substantial associated readmission rates. It is unknown how cost-constrictive payment reform measures, such as Maryland's...
6.
Gunawardane S, Kramer M, Bearden J, Resar J, Lawton J, Allison D, et al.
Int J Surg Case Rep
. 2022 Mar;
92:106894.
PMID: 35278985
Introduction And Importance: Atrial myxomas account for more than half of all cardiac tumors. While the symptoms of these are many, the most prominent among them being migraines, heart failure,...
7.
Forrest J, Deeb G, Yakubov S, Rovin J, Mumtaz M, Gada H, et al.
J Am Coll Cardiol
. 2022 Mar;
79(9):882-896.
PMID: 35241222
Background: The Evolut Low Risk Trial (Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients) showed that transcatheter aortic valve replacement (TAVR) with a supra-annular, self-expanding valve was noninferior...
8.
Ijaz N, Buta B, Xue Q, Mohess D, Bushan A, Tran H, et al.
J Am Coll Cardiol
. 2022 Feb;
79(5):482-503.
PMID: 35115105
With the aging of the world's population, a large proportion of patients seen in cardiovascular practice are older adults, but many patients also exhibit signs of physical frailty. Cardiovascular disease...
9.
Das T, Shin J, Czarny M, Nanavati J, Resar J, Hasan R
Catheter Cardiovasc Interv
. 2021 Nov;
99(4):1225-1233.
PMID: 34792259
Objectives: We aimed to evaluate the risk of procedural complications after TAVR using secondary radial access (RA) versus femoral access (FA) through a systematic review and meta-analysis of the published...
10.
Damluji A, Chung S, Xue Q, Hasan R, Moscucci M, Forman D, et al.
Eur Heart J
. 2021 Jul;
42(37):3856-3865.
PMID: 34324648
Aims: Physical frailty is a commonly encountered geriatric syndrome among older adults without coronary heart disease (CHD). The impact of frailty on the incidence of long-term cardiovascular outcomes is not...